Castres, France

Jean-Marc Barret

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 4.3

ph-index = 2

Forward Citations = 17(Granted Patents)


Location History:

  • Toulouse, FR (2019)
  • Castres, FR (2000 - 2021)

Company Filing History:


Years Active: 2000-2021

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Jean-Marc Barret: Pioneering Advances in Antibody Therapeutics

Introduction

Jean-Marc Barret, a prominent inventor located in Castres, France, has made significant contributions to the field of biomedicine with a total of nine patents to his name. His innovative work primarily focuses on the development of antibodies used in cancer treatment, marking him as a notable figure in the research and medical communities.

Latest Patents

Among his latest inventions is a groundbreaking anti-human-HER3 antibody designed to target cancer cells more effectively. This specific antibody is characterized by its non-competitive allosteric nature, featuring a human constant region and a unique glycosylation profile with less than 65% of its glycan structures carrying a fucose molecule. Furthermore, another notable patent relates to antibody drug conjugates (ADCs) and various antibody conjugates (ACs) that specifically bind to the human anti-Müllerian hormone type II receptor (AMHR-II). This invention holds promise in treating cancers that express AMHR-II, including prostate cancer, breast cancer, and various gynecologic cancers, foremost among them metastatic ovarian cancer.

Career Highlights

Throughout his career, Jean-Marc Barret has been affiliated with renowned firms, including Pierre Fabre Medicament and Adir Et Compagnie. His expertise in antibody technology and therapeutic applications has significantly advanced medical treatment methodologies.

Collaborations

During his professional journey, Jean-Marc has collaborated with esteemed colleagues such as Thierry Imbert and Yves Guminski. These partnerships have been instrumental in driving innovative solutions in the field of antibodies and cancer therapeutics.

Conclusion

With a steadfast commitment to medical innovation, Jean-Marc Barret continues to pave the way for advancements in antibody-based therapies. His inventions reflect a deep understanding of biopharmaceutical science and a dedication to improving patient outcomes through targeted treatments. As research continues, Barret's contributions are sure to leave an indelible mark on the medical landscape.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…